Log in
NASDAQ:CRSP

Crispr Therapeutics Earnings Date, Estimates & History

$91.82
-4.53 (-4.70 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$90.01
Now: $91.82▼
$96.69
50-Day Range
$79.67
MA: $90.85▼
$109.83
52-Week Range
$32.30
Now: $91.82▼
$111.90
Volume1.05 million shs
Average Volume1.39 million shs
Market Capitalization$6.44 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.31

Earnings

Crispr Therapeutics (NASDAQ:CRSP) Earnings Information

Crispr Therapeutics last issued its quarterly earnings data on November 2nd, 2020. The reported ($1.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.18) by $0.14. The company had revenue of $0.15 million for the quarter, compared to analysts' expectations of $2.22 million. Its revenue was down 99.9% on a year-over-year basis. Crispr Therapeutics has generated $1.17 earnings per share over the last year. Crispr Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 10th, 2021 based off prior year's report dates.

Crispr Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Crispr Therapeutics (NASDAQ:CRSP) Earnings Estimates

2020 EPS Consensus Estimate: ($4.69)
2021 EPS Consensus Estimate: ($6.13)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($1.20)($1.00)($1.09)
Q2 20205($1.30)($0.77)($1.07)
Q3 20206($1.39)($1.08)($1.25)
Q4 20206($1.49)($1.12)($1.29)
Q1 20214($1.65)($1.26)($1.45)
Q2 20214($1.81)($1.28)($1.55)
Q3 20214($1.88)($1.29)($1.58)
Q4 20213($1.96)($1.30)($1.56)

Crispr Therapeutics (NASDAQ CRSP) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/10/2021
(Estimated)		       
11/2/20209/30/2020($1.18)($1.32)($1.32)$2.22 million$0.15 millionN/A
7/27/20206/30/2020($0.95)($1.30)($1.30)$19.77 million$0.04 millionN/A
4/28/20203/31/2020($1.05)($1.15)($1.15)$3.04 million$0.16 millionN/A
2/12/2020Q4 2019($0.68)$0.51$0.51$39.08 million$77.00 millionN/A
10/28/2019Q3($0.9480)$2.40$2.40$6.32 million$211.93 millionN/A
7/29/2019Q2($0.17)($1.01)($1.01)$47.57 million$0.32 millionN/A
4/29/2019Q1($0.90)($0.93)($0.93)$1.50 million$0.30 millionN/A
2/25/2019Q4 2018($0.83)($0.92)($0.92)$1.56 million$0.10 millionN/A
11/8/2018Q3($0.74)($1.07)($1.07)$2.64 million$0.56 millionN/A
8/8/2018Q2($0.6310)($0.82)($0.82)$1.47 million$1.09 millionN/A
5/9/20183/31/2018($0.67)($0.62)($0.62)$3.64 million$1.36 millionN/A
11/8/2017Q3($0.60)($0.62)($0.62)$3.61 million$2.39 millionN/A
8/10/20176/30/2017($0.62)($0.56)($0.56)$3.29 million$3.60 millionN/A
5/11/20173/31/2017($0.60)($0.54)($0.54)$2.70 millionN/A
3/10/2017Q4 2016($0.38)($0.40)($1.20)$2.34 millionN/A
11/22/2016Q3 2016($2.77)($2.77)$1.55 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 10/31/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.